In fact, NOTCH1/2 mutations have been reported at a frequency of <5% in MDS and 12% in AML patients, but the direct evidence of NOTCH1/2 mutation implicated in MDS is limited [8,55,56]. Here, NOTCH1 is linked to acute myeloid leukemia.